SGHI FHIR Profile Implementation Guide
0.1.0 - ci-build
SGHI FHIR Profile Implementation Guide, published by Kathurima Kimathi. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/savannahghi/sil_fhir_profile_ig/ and changes regularly. See the Directory of published versions
| Active as of 2026-09-15 |
{
"resourceType" : "CodeSystem",
"id" : "kepi-antigen",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem kepi-antigen</b></p><a name=\"kepi-antigen\"> </a><a name=\"hckepi-antigen\"> </a><p>This code system <code>https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">bcg<a name=\"kepi-antigen-bcg\"> </a></td><td>BCG</td><td>Bacille Calmette-Guerin vaccine, given at birth against tuberculosis.</td></tr><tr><td style=\"white-space:nowrap\">bopv<a name=\"kepi-antigen-bopv\"> </a></td><td>Bivalent oral poliovirus vaccine</td><td>Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks.</td></tr><tr><td style=\"white-space:nowrap\">ipv<a name=\"kepi-antigen-ipv\"> </a></td><td>Inactivated poliovirus vaccine</td><td>Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them.</td></tr><tr><td style=\"white-space:nowrap\">penta<a name=\"kepi-antigen-penta\"> </a></td><td>DTP-HepB-Hib (pentavalent) vaccine</td><td>Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks.</td></tr><tr><td style=\"white-space:nowrap\">pcv10<a name=\"kepi-antigen-pcv10\"> </a></td><td>Pneumococcal conjugate vaccine (PCV10)</td><td>Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks.</td></tr><tr><td style=\"white-space:nowrap\">rota<a name=\"kepi-antigen-rota\"> </a></td><td>Rotavirus vaccine</td><td>Oral rotavirus vaccine, given at 6 and 10 weeks.</td></tr><tr><td style=\"white-space:nowrap\">mr<a name=\"kepi-antigen-mr\"> </a></td><td>Measles-rubella vaccine</td><td>Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years.</td></tr><tr><td style=\"white-space:nowrap\">yf<a name=\"kepi-antigen-yf\"> </a></td><td>Yellow fever vaccine</td><td>Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone.</td></tr></table></div>"
},
"url" : "https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen",
"version" : "0.1.0",
"name" : "SGHIKEPIAntigenCodeSystem",
"title" : "SGHI KEPI Antigen",
"status" : "active",
"date" : "2026-09-15T11:40:24+00:00",
"publisher" : "Kathurima Kimathi",
"contact" : [
{
"name" : "Kathurima Kimathi",
"telecom" : [
{
"system" : "url",
"value" : "https://www.linkedin.com/in/kathurima-kimathi/"
},
{
"system" : "email",
"value" : "kathurimakimathi415@gmail.com"
}
]
},
{
"name" : "Oscar John",
"telecom" : [
{
"system" : "email",
"value" : "oscarjohnotieno@gmail.com",
"use" : "work"
}
]
},
{
"name" : "Kennedy Omondi",
"telecom" : [
{
"system" : "email",
"value" : "kennankole@gmail.com",
"use" : "work"
}
]
}
],
"description" : "Antigens administered under the Kenya Expanded Programme on Immunisation, as recorded on the MOH 510 Immunisation Permanent Register. One concept per antigen: the dose within a series is carried separately on Immunization.protocolApplied.doseNumber, which is what keeps IPV distinct from bivalent OPV and separates the three pentavalent doses. Pending a mapping to CVX or the national antigen list.",
"content" : "complete",
"count" : 8,
"concept" : [
{
"code" : "bcg",
"display" : "BCG",
"definition" : "Bacille Calmette-Guerin vaccine, given at birth against tuberculosis."
},
{
"code" : "bopv",
"display" : "Bivalent oral poliovirus vaccine",
"definition" : "Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks."
},
{
"code" : "ipv",
"display" : "Inactivated poliovirus vaccine",
"definition" : "Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them."
},
{
"code" : "penta",
"display" : "DTP-HepB-Hib (pentavalent) vaccine",
"definition" : "Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks."
},
{
"code" : "pcv10",
"display" : "Pneumococcal conjugate vaccine (PCV10)",
"definition" : "Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks."
},
{
"code" : "rota",
"display" : "Rotavirus vaccine",
"definition" : "Oral rotavirus vaccine, given at 6 and 10 weeks."
},
{
"code" : "mr",
"display" : "Measles-rubella vaccine",
"definition" : "Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years."
},
{
"code" : "yf",
"display" : "Yellow fever vaccine",
"definition" : "Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone."
}
]
}